Last reviewed · How we verify
The Royal Ottawa Mental Health Centre — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
1 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Psychiatry / Neurology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Children's Hospital Medical Center, Cincinnati · 1 shared drug class
- Hospital de Clinicas de Porto Alegre · 1 shared drug class
- Oregon Health and Science University · 1 shared drug class
- Orient Pharma Co., Ltd. · 1 shared drug class
- Pfizer · 1 shared drug class
- St. Louis University · 1 shared drug class
- UCB Pharma · 1 shared drug class
- University of California, San Francisco · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for The Royal Ottawa Mental Health Centre:
- The Royal Ottawa Mental Health Centre pipeline updates — RSS
- The Royal Ottawa Mental Health Centre pipeline updates — Atom
- The Royal Ottawa Mental Health Centre pipeline updates — JSON
Cite this brief
Drug Landscape (2026). The Royal Ottawa Mental Health Centre — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/the-royal-ottawa-mental-health-centre. Accessed 2026-05-17.